Myungmoon Pharm. Co.   Report issue

For profit Phase 4
Founded: Seoul Korea, Republic of (1983)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00685542
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

diacerein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1